1. Home
  2. INMD vs PHAR Comparison

INMD vs PHAR Comparison

Compare INMD & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InMode Ltd.

INMD

InMode Ltd.

HOLD

Current Price

$14.81

Market Cap

842.0M

Sector

Health Care

ML Signal

HOLD

Logo Pharming Group N.V.

PHAR

Pharming Group N.V.

HOLD

Current Price

$13.77

Market Cap

885.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INMD
PHAR
Founded
2008
1988
Country
Israel
Netherlands
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
842.0M
885.7M
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
INMD
PHAR
Price
$14.81
$13.77
Analyst Decision
Hold
Strong Buy
Analyst Count
5
3
Target Price
$17.33
$38.33
AVG Volume (30 Days)
739.4K
4.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.74
$10.04
Revenue Next Year
$3.26
$2.51
P/E Ratio
$10.11
$3,041.22
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$9.54
52 Week High
$16.74
$21.34

Technical Indicators

Market Signals
Indicator
INMD
PHAR
Relative Strength Index (RSI) 66.80 57.84
Support Level $14.58 $12.98
Resistance Level $15.23 $17.60
Average True Range (ATR) 0.27 0.38
MACD 0.14 0.19
Stochastic Oscillator 80.30 86.30

Price Performance

Historical Comparison
INMD
PHAR

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

About PHAR Pharming Group N.V.

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Share on Social Networks: